Yi He

ORCID: 0009-0008-1563-140X · 3 papers in corpus
2026
·doi:10.1016/j.asjsur.2026.03.138
review 2026
Research (Washington, D.C.) ·doi:10.34133/research.1106

Metabolism-regulating microspheres have evolved from conventional drug carriers into active platforms capable of spatiotemporally reprogramming pathological metabolic networks. Chronic diseases are increasingly understood to be driven by me…

lab-animal 2012
Angiogenesis ·doi:10.1007/s10456-012-9299-4

Green tea epigallocatechin-3-gallate (EGCG) can inhibit angiogenesis and development of an experimental endometriosis model in mice, but it suffers from poor bioavailability. A prodrug of EGCG (pro-EGCG, EGCG octaacetate) is utilized to enh…